Download Research Projects and Mentors List

UBC Department of Medicine Research Projects & Mentors List 2013/2014
MENTOR
RESEARCH INTEREST
# RES.
Email
3-5
2
[email protected]
[email protected]
[email protected]
AIDS
Dr. Julio Montaner
Dr. Thomas Kerr
Dr. Evan Wood
1. HIV/AIDS
1. HIV/AIDS
1. HIV/AIDS
2. Additional Medicine
3. GIM / inner city medicine
Dr. Amin Kanani
Dr. Robert Schellenberg
1. Adult primary immunodeficiency
1. Aspirin-induced asthma
2. Anaphylaxis
1. Oral Allergy Syndrome
2. Mosquito Allergy
3. Eosinophilic Esophaitis Treatment
1. Complementary & Alternative Medicine (CAM)
2. Allergic and adverse reactions from CAM and herbal
medicine
3. Medical education in CAM and herbal medicine
ALLERGY / IMMUNOLOGY
Dr. Donald F. Stark
Dr. George Wong
1
1
[email protected]
[email protected]
1-2
[email protected]
1
[email protected]
1
1-2
[email protected]
[email protected]
1-2
[email protected]
CARDIOLOGY
Dr. Ron Carere
Dr. Sammy Chan
Dr. Ken Gin
Dr. Jaap N. Hamburger
Dr. Karin Humphries
Dr. Andrew Ignaszewski
Dr. Saul Isserow
Dr. John Jue
Dr. Charles Kerr
Dr. Scott Lear
Dr. John Mancini
Dr. Henry Mizgala
Dr. Brad Munt
Dr. Jim Nasmith
Dr. Ian Penn
Dr. Alan Rabinowitz
Dr. Simon Rabkin
Dr. Don Ricci
Dr. Lynn Straatman
Dr. J. Webb
Dr. Jasmine Grewal
Dr. Carolyn M Taylor
Dr. Mustafa Toma
1. Interventional cardiology
1. Relationship between endothelial progenitor cells and
cardiac risk factors
2. Endothelial function
3. Exercise training
4. Pre-clinical atherosclerosis
1. ECG, MI, CHF, PFO, General Cardiology
2. Amiodarone, Atrial Fibrillation, Arrhythmias
3. 18 Lead ECG
4. Lewis Leads
5. Exercise Treadmill Testing
6. Echo: BNP - Troponin
1. Autologous bone marrow stem cell implantation for
cardiovascular repair
1. Cardiovascular epidemiology
2. Health outcomes post revascularization
3. Sex differences in health services access/outcomes
4. Administrative data linkage/outcomes research
5. Randomized controlled trials
1. Heart failure
2. Heart transplantation
3. Atherosclerosis reversal
4. Cardiac rebels and prevention
1. Cardiac involvement in myopathic diseases
2. Preventive Cardiology - outcomes research
1. Clinical application of ECG's including 12, 15, 18 lead
ECG’s
2. Clinical applications of treadmill testing
3. 24 hour holter monitoring
4. Clinical applications of Echo/Doppler
1. Atrial fibrillation -follow-up
2. Pacemakers & defibrillators
1. Cardiac rehabilitation
2. Obesity
3. Ethnic predisposition for CVD
4. Primary prevention
1. Quantitative angiography
2. Carotid ultrasound
3. Endothelial dysfunction
4. cardiac computed tomography
5. Atherosclerosis reversal
1. CHF; ACE inhibitors
2. Cough secondary to AVE inhibitors
3. Review of longterm results of cardiac patient in patients
with 2* heart block
1. Echocardiography
2. Heart failure
3. Valve disease
1. The relation between the ECG and the vascular
pathology of coronary artery disease.
1. Genetics of premature atherosclerosis in Fijian East
Indian population
1. Acute coronary syndromes
2. Chronic disease management in vascular disease
1. Aortic valve disease
2. Blood pressure and CV disease
3. Genetics of CV disease
4. Fundamental mechanisms of cardiac disease
1. Cardiac stents
2. Cardiac function
3. Valvular heart disease
4. Myocondial ischemia
1. Adolescent Healthcare Transitions
2. Palliative Care
3. Heart Failure and Heart Transplantation
4. Congenital Heart Disease
5. Cardiomyopathy
1. Interventional cardiology
2. New interventional devices
3. Myocardial infarction/shock
1. Adult congenital heart disease
2. Pregnancy and heart disease
3. Echocardiography
1. Cardiac CT Angiography
2. Cardiac rehabilitation and prevention
3. Exercise stress testing
4. Sex differences in CAD
5. Ethnic differences in CAD
1. Heart Failure
2. Mechanical circulatory support
3. Heart transplant
1
[email protected]
2
[email protected]
1-2
[email protected]
2
[email protected]
2
[email protected]
1
[email protected]
1
[email protected]
1
[email protected]
2
[email protected]
2
[email protected]
1
[email protected]
1-2
[email protected]
1
[email protected]
2
[email protected]
2
[email protected]
1
[email protected]
1
[email protected]
2
[email protected]
2
[email protected]
2
[email protected]
1
CRITICAL CARE MEDICINE
Dr. Dean Chittock
Dr. Vinay Dhingra
Dr. Peter Dodek
Dr. Delbert Dorscheid
Dr. David Forrest
Dr. Juan Ronco
Dr. Jim Russell
Dr. John Tsang
Dr. Keith Walley
1. Clinical epidemiology
2. Sepsis and septic shock
3. Lung injury
4. Outcomes
1. Glucose control in critical illness
2. Contrast nephropathy in critical care
3. Fluid resuscitation in sepsis
4. Medical education in ICU
1. Role of organizational factors in outcomes of critical
care
2. Development, implementation, and evaluation of clinical
practice guidelines in critical care
3. Patient safety processes and outcomes in critical care
4. Moral distress in ICU Personnel
1. Asthma
2. Inflammation and Apoptosis
3. Ischemia/Reperfusion Cardiac Injuries
1. Antibiotic usage in ICU
2. Immunomodulation of infection
3. Cardiac arrest outcomes
4. End of life decision making
1. Mechanical ventilation
2. ARDS
3. Tissue oxygenation/ischemia
1. Clinical Scoring systems in critical care
2. Gastric tonometry in critical care
3. Effects of transfusion on health outcomes
4. ARDS - epidemiology therapy
5. Tissue hypoxia
6. AIDS database
7. Medicine database
1. Endothelins
2. Pulmonary embolism
3. Gas exchange in acute lung injury
1. Cardiac dysfunction in critical illness
2. Sepsis and septic shock
3. Oxygen extraction by peripheral tissues
4. Cardiovascular physiology
[email protected]
1-2
[email protected]
1-2
[email protected]
2-3
[email protected]
[email protected]
1-2
[email protected]
1-2
[email protected]
[email protected]
4
[email protected]
5. Genetic determinants of outcome of complex diseases
DERMATOLOGY
Dr. Alastair Carruthers
Dr. Jan Dutz
Dr. Brian Gregory
Dr. Vincent Ho
Dr. Neil Kitson
Dr. Brian T. Kunimoto
Dr. Gang Li
Dr. Harvey Lui
Dr. Jerry Shapiro
Dr. M. Shokravi
Dr. Larry Warshawski
Dr. Haishan Zeng
Dr. Youwen Zhou
1. Botulinum toxin
2. Tissue augmenting agents
3. Resurfacing techniques
4. HIV-associated lipodystrophy / lipoatrophy
1. PUVA for sclerotic skin disease (clinical)
2. UV light and systemic lupus (clinical)
3. Antigen presentation of the skin (basic)
1. General Dermatology
2. Medical Economics
3. Acutane & Retinoids
1. Skin cancer
2. Immunodermatology
1. Clinical use of methotrexate
2. Longterm toxicity of retinoids
3. Dermatology education for General Medicine
4. Gold in psoriatic arthritis
1. Wound Healing
1. Skin cancer
2. Tumor suppressor
3. UV signal transduction
4. Melanoma treatment
1. Photo medicine
2. Psoriasis
3. Medical informatics
4. Laser medicine
1. Hair - Clinical & basic science
1. Patients’ compliance to instructions given in a
dermatology outpatient clinic.
2. Association between depression and Accutane.
3. What is the true frequency of the applications of
creams done at home,
compared to what is instructed?
4. Clinical: What is the compliance rate of patients to
dermatologists’ instruction
in an out patient setting?
1. Skin cancer
2. Tissue augmentation
3. Skin resurfacing
1. Photomedicine
2. Optical imaging and spectroscopy
3. Non-invasive diagnosis
4. Early cancer detection
1. Melanoma and pigmentation
2. Molecular disease markers
3. Clinical genomics
[email protected]
2
[email protected]
1
phone: 604-876-7222
no email listed
1
[email protected]
1
[email protected]
[email protected]
[email protected]
1
[email protected]
2
2
[email protected]
phone: (604) 984-1244
no email listed
1
[email protected]
[email protected]
1-2
[email protected]
2
ENDOCRINOLOGY
Dr. Richard Bebb
Dr. G. Bondy
Dr. Tom Elliott
Dr. Sabrina Gill
Dr. Michelle Johnson
Dr. David Kendler
Dr. Stuart Kreisman
Dr. Graydon Meneilly
Dr. Jerilynn Prior
Dr. S. Sirrs
Dr. David Thompson
Dr. Hugh Tildesley
Dr. Clarissa Wallace
Dr. Graeme E. Wilkins
1. Aging male
2. Diabetes
3. Lipids
4. General Endocrinology
1. Nutitional treatment of dyslipidemias
2. Metabolic side effects of antiretroviral therapy
3. Nuclear hormone receptors & regulation of metabolism
4. Hormonal regulation of cardiac metabolism
1. Diabetes Clinical Trials
1. Female Reproductive Disorders
2. Osteoporosis
3. Diabetes
4. Evaluate vitamin D in patients with osteoporosis
5. A project to update and write up (PCOS and metabolic
disease)
1. Pituitary Disease
2. Macroprolactin
3. Adult Growth Hormone Deficiency
1. Osteoporosis
2. Thyroid Autoimmune Disease
1. Cystic Fibrosis - related diabetes
2. Thyroid disease
1. Diabetes in the Elderly
2. Carbohydrate Metabolism
3. Incretins
1. Osteoporosis and Fractures in young woman - causes
& therapy
2. Perimenopause - endocrinology, bone change, causes
for symptoms, therapy
3. Ovulation disturbances - diagnosis, prevalence &
incidence as well as appropriate
therapy
4. Hot flushes - pathophysiology and therapy
5. Epidemiology of menstrual cycles, ovulation, short
luteal phase
6. Progesterone as a therapy for osteoporosis - bone
formation/fracture prevention
1. Inborn errors of metabolism
2. Fabry disease
3. Dyslipidemias
1. Diabetes
1. Diabetes outcome
2. Assessment of new therapies in D.M.
1. General endocrinology including diabetes (community
based)
1. General Endocrinology
1-2
[email protected]
1
[email protected]
1-2
1-2
[email protected]
[email protected]
[email protected]
3
[email protected]
[email protected]
[email protected]
2
[email protected]
1-2
[email protected]
1-2
[email protected]
(604) 689-1055
no email listed
[email protected]
2
[email protected]
1-2
[email protected]
[email protected]
GASTROENTEROLOGY
Dr. Frank Anderson
Dr. Michael Byrne
Dr. Hugh Chaun
Dr. Robert Enns
Dr. Marty Fishman
Dr. Hugh Freeman
Dr. Jim Gray
Dr. Peter Kwan
Dr. Bill Salh
Dr. Urs Steinbrecher
Dr. Isabella Tai
Dr. Jennifer Telford
Dr. A. Weiss
Dr. Eric Yoshida
1. Hepatitis C
2. Hepatitis B
3. Inflammatory Bowel Disease
1. Helicobacter Pylori
2. Cylcooxygenase - 2 (COX-2)
3. ERCP, EUS (endoscopic ultrasound) - clinical aspects
4. Pancreatitis
5. Therapeutic Endoscopy - clinical aspects
1. GI complications in adult cystic fibrosis
2. GI disorders: "Western diseases, eastern trends"
3. History of medicine and gastroenterology
1. Capsule endoscopy
2. Gastrointestinal Bleeding - outcomes related to
medical/endoscopic therapy
3. Patient satisfaction studies in endoscopy
4. Resource utilization in endoscopic procedures.
1. General Clinical Gastroenterology
3. Inflammatory Bowel Disease
1. IBD (Crohn's disease UC collagens and Lymphocytic
Colitis)
2. Hollow organ GI disease
3. Colon Cancer and precancer
4. Coliac disease
1. Clinical Gastroenterology
1. Hepatitis B, C
2. IBD
1. Inflammatory Bowel Disease
2. Colon Cancer
3. Demographic Trends in GI Diseases
1. Lipoprotein metabolism / atherosclerosis
2. Hepatology
1. GI Oncology
2. Chemotherapy Resistance (basic science)
3. Diagnostic and Prognostic Biomarker Discovery
(translational research)
4. Microarray analysis (basic science)
1. Use of endoscopic techniques in the palliation of GI
malignancies
2. Endoscopic ultrasound for the early diagnosis and
staging of malignancy
3. Colorectal cancer screening strategies and public
awareness
1. GI Oncology
2. Therapeutic Endoscopy
1. Liver Disease
2. Transplantation
3. Epidemiology or Bioethics
4. General GI
1-2
[email protected]
4-6
[email protected]
1
[email protected]
1-2
[email protected]
1-2
[email protected]
[email protected]
1-2
[email protected]
1-2
[email protected]
2
[email protected]
1-2
[email protected]
1
[email protected]
1-2
[email protected]
3
GENERAL INTERNAL MEDICINE
Dr. Ric Arseneau
Dr. Laird Birmingham
Dr. Jim Busser
Dr. Alex Chan
Dr. Jim Dunne
Dr. Rose Hatala
Dr. Barry Kassen
Dr. Iain Mackie
Dr. Laura A. Magee
Dr. May Ong-Lam
Dr. Anita Palepu
Dr. Tom Perry
Dr. Mark Roberts
Dr. Stephen Van Eeden
Dr. Jim Wright
1. Medical education / evaluation
1. Eating disorders and obesity
2. Mineral disorders including magnesium, zinc
3. Clinical epidemiology
1. Venous thromboembolism / DUT / anticoagulation
2. Any common CTU clinical problem
3. Medical informatics (computers in medicine)
4. Clinical trial design
5. Clinical skills
Addictions Medicine:
- B257Access & utilization of resources
- Alcohol withdrawal
2. General Internal Medicine:
CTU related problems, Medication errors and Diabetes
1. Investigation of Raynaud's
2. Endothelial cell function
3. QOL in scleroderma
1. Medical Education—evaluation methods
2. Simulation-based medical education
3. Clinical reasoning
1. Safety
2. Quality
3. Education
4. Clinical
1. Predictive value of Serum Lactate in the diagnosis of
Abdominal Pain
2. TB & HIV Infection
3. HIV Infection & Injection Drug Users
4. Echocardiography in Stroke/TIA
1. Management of Pregnancy Hypertension
2. Pre-Eclampsia
3. Medical complications of Pregnancy
1. Complex regional pain syndrome
2. Neuropathic pain
3. Longterm opiates in non-malignant pain
4. Post traumatic headache
1. Homelessness, housing and health
2. Quality of life among vulnerable groups
3. Peer review science
4. Open access publishing
1. Clinical Pharmacelogy of Adverse Drug Reactions
2. Development of teaching videotapes for clinical
pharmacology and therapeutics and general medicine
3. Critical appraisal of RCT's
4. Quality of care in hospital
1. Peri-operative medicine
2. Exercise Physiology
1. Pneumonia; Lung Infection
2. Leukocyte biology
3. Air pollution, COPD
4. Stem cells in inflammation
1. Hypertension
2. Antihypertensive drug trials
3. Drug interactions
4. Systematic reviews
5. Evidence Based Drug Therapy: Critical Appraisal
1
1-2
[email protected]
[email protected]
1
[email protected]
1-2
[email protected]
1
[email protected]
1
[email protected]
1-2
[email protected]
1
[email protected]
[email protected]
1
[email protected]
1
[email protected]
1
[email protected]
2
[email protected]
1-2
[email protected]
1
[email protected]
1-2
[email protected]
[email protected]
GERIATRICS
Dr. Wendy Cook
Dr. Larry Dian
Dr. Janet Kushner Kow
Dr. Roger Wong
1. Physical performance measures for clinical
assessment
2. Fall risk assessment
1. Fall risk assesment
2. Osteoporosis, fracture risk assesment
1. Medical Education
2. Interdisciplinary teams in Geriatrics
3. Restraint use
1. Medical Education
2. Acute care for the elderly
3. Functional performance in the elderly
1
[email protected]
1-2
[email protected]
HEMATOLOGY
Dr. Donna Forrest
Dr. Paul Galbraith
Dr. Donna Hogge
Dr. Chantel Leger
Dr. Heather Leitch
Dr. Steve Nantel
Dr. Tom Nevill
Dr. Tanya Petraszko
Dr. John Shepard
Dr. Heather Sutherland
Dr. C. Toze
Dr. Linda Vickars
1. Stem Cell Transplantation
2. Chronic Myeloid Leukemia
3. Second Malignancies Post-Transplant
1. General Hematology
1. Acute leukemia
2. Stem Cell transplantation
3. Normal and malignant stem cell biology
4. Targeted therapy for acute myeloid leukemia
1. General Hematology
2. Malignant Hematology
1. Hematologic Malignancies
2. Targeted Therapy
3. AIDS-related lymphoma
1. Hematology - any interests
1. Bone marrow transplantation
2. Acute and Chronic Leukemia
3. Graft-versus host disease
1. Transfusion Medicine
2. Apheresis Medicine / Plasma Exchange
1. Acute leukemia & bone marrow therapies
2. Various projects available from case reports; series;
original proposals
1. Stem Cell Transplant
2. Multiple Myeloma
1. Hematologic Malignancies
2. Hematopoetic Stem Cell Transplantation
3. Indolent Lymphoid Malignancies
4. Epidemiology and Decision Analysis
1. Thrombosis and hemostasis
2. Hemoglobinopathies
3. Anticoagulation therapy
1
[email protected]
1
[email protected]
[email protected]
1
[email protected]
2
[email protected]
1-2
1
[email protected]
[email protected]
1
[email protected]
1
[email protected]
1
[email protected]
1
[email protected]
1-2
[email protected]
4
INFECTIOUS DISEASES
Dr. Yossef Av-Gay
Dr. Bill Bowie
Dr. Robert C. Brunham
Dr. Art Cherkasov
Dr. Zakaria Hmama
Dr. David Patrick
Dr. Peter Phillips
Dr. Neil Reiner
Dr. Robert Reynolds
Dr. Grant Stiver
Dr. Mark Tyndall
1. Molecular Genetics of Mycobacteria
2. Release of Genetically Modified Micro-organisms to the
Environment
1. Infections related to water, food, ticks
2. Travel related infections, including malaria
3. Sexually transmitted diseases
4. Necrotizing fasciitis
1. Chlamydia Immunology
2. Chlamydia genomics
3. HLA conelates of Immunity
1. Infectious drug targets
2. Drug Design
3. Bioinformatics
4. Antibitics
Interaction between Mycobacterium & host cell
1. Signaling regulating phagocytosis of mycobacteria
2. Mycobaterial phagosome biogenesis
3. Modulation of MHC class II expression in macrophage
infected w/ mycobacterium
1. Control of Antimicrobial Resistance in Populations
2. Antimicrobial Stewardship (Community, Agriculture,
Institution)
3. Responses to Emerging Infectious Diseases
1. HIV-related opportunistic infections
2. Fungal infections
1. Macrophages in host defense
2. Tuberculosis
3. Leishmaniasis
4. Macrophage cell regulation
1. Tropical Medicine
2. HIV / AIDS
3. Case presentations & and literature reviews
1. Influenza and pneumonia
2. Antibiotic therapy & prophylaxis
3. Skin infections - bacteremia, etc.
1. HIV / AIDS
2. Epidemiology of HIV transmission
3. Harm reduction among injection drug users
[email protected]
2
[email protected]
[email protected]
1
[email protected]
1-2
[email protected]
1
[email protected]
2
[email protected]
1
[email protected]
1-2
[email protected]
2-3
[email protected]
1
[email protected]
1
[email protected]
1
[email protected]
1-2
[email protected]
MEDICAL ONCOLOGY
Dr. Andrew Attwell
(Victoria)
Dr. Vanesa Bernstein
(Victoria)
Dr. Winson Cheung
Dr. Kim N. Chi
Dr. Stephen Chia
Dr. Joseph Connors
Dr. Karen Gelmon
Dr. Sharlene Gill
Dr. Cheryl Ho
Dr. Hagen Kennecke
Dr. Meg Knowling
Dr. Janessa Laskin
Dr. Christopher Lee
(Surrey)
Dr. Howard Lim
Dr. Nicol Macpherson
(Victoria)
Dr. Laurie Sehn
Dr. Bernie Eigl
Dr. Diego Villa
Dr. Daniel Renouf
Dr. Lee Ann Martin
Dr. Anna Tinker
Dr. Janine Davies
(Kelowna, BCCA - Centre for
the Southern Interior)
1. Breast cancer
2. GU
3. Brain
1. Breast cancer
2. PET in oncology
3. Hot flashes in breast cancer patient
1. Cancer health services/outcomes
2. Database analyses
3. Survey development
1. Prostate cancer
2. Genitourinary cancers
3. Investigational new drugs
1. Breast cancer
2. Head and neck cancer
3. Investigational new drug development
Lymphoproliferative disease, lymphoma
1. Breast cancer
2. New investigational drugs
1. Colorectal cancers
2. GI cancers
3. Outcomes research
1. Lung Cancer
2. Head & Neck
1. Hormonal therapies for breast cancer
2. Colon and rectal cancer
3. Colorectal Cancer
4. Neuroendocrine cancers
5. Biomarker Research
6. Clinical trials
1. Locally Advanced Sarcoma
2. Osteosarcoma
3. GIST
1. Lung Cancer
2. Head & Neck Cancer
1. Lung cancer
2. Health-related quality of life assessment
3. Health services / outcomes research
1. GI Cancer Outcomes Research
1. Breast cancer
2. Lymphoms and myeloma
3. Research to identify which patients benefit from
chemotx
1. lymphoproliferative disease
2. lymphoma
1. Genitourinary cancers
2. Clinical trial operations/health services
1. Lymphoproliferative diseases
2. Breast cancer
1. Pancreatic cancer
2. Investigational new drugs
3. Gastrointestinal cancer outcomes
Health service delivery. This include
- diagnostic wait times and pathways (community based)
in oncology
- community emergency department recognition and
treament of chemotherapy toxicities
- survivorship in breast and ovarian cancer
- qualitative research in oncology healthcare delivery
- locally advanced breast cancer
- health professional moral distress in the oncology setting
- measurement of acuity/complexity in oncology outpatient treatment
- Ethics of health service delivery
1. Ovarian cancer
2. Endometrial cancer
3. Gynecologic cancer survivorship
1. GI Oncology
[email protected]
1-2
[email protected]
1
[email protected]
[email protected]
1-2
[email protected]
1-2
[email protected]
[email protected]
1
[email protected]
1
[email protected]
[email protected]
1
1-2
[email protected]
[email protected]
[email protected]
[email protected]
[email protected]
[email protected]
1
[email protected]
1
[email protected]
[email protected]
2. Clinical trials, phase I trails
3. Surveillance in CRC, outcomes in GI cancers
5
NEPHROLOGY
Dr. Mike Copland
Dr. John Duncan
Dr. John Gill
Dr. J. Jastrzebski
Dr. Paul Keown
Dr. Mercedeh Kiaii
Dr. Adeera Levin
Dr. Jean Shapiro
Dr. R.S. Singh
1. Nocturnal (quotidian) hemodialysis
1. Gender differences in kidney diseases
2. Renal artery stenosis
1. Clinical outcomes in kidney transplant recipients
2. Safety of live kidney donation
3. Immune surveillance in kidney transplant recipients
4. Living anonymous kidney donation
1. Vascular access for hemodiaylsis
1. Clinical trials in transplant, health economics and
outcomes
2. Molecular studies of immunosuppressive drugs
1. Hemodialysis : Clinical practice guidelines
2. Hemodialysis: On-line hemodynamic monitoring
3. Hemodialysis: Vascular access
1. Epidemiology of early renal insufficiency / ions
2. Pathophysiology of progressive renal disease
3. Cardiovascular disease in renal populations
4. Predicting high risk populations in renal disease
1. Renal transplantation clinical outcomes
2. Cognitive dysfunction in CRF
1. Peritoneal dialysis: lipid management
2. Fluid and electrolyte disorders
3. Reading (Postgrad) Education. Outcome (exam).
1
1-2
[email protected]
[email protected]
2
[email protected]
1
1-2
[email protected]
[email protected]
1
[email protected]
1-2
[email protected]
2
[email protected]
1-2
[email protected]
1-2
[email protected]
1-2
[email protected]
NEUROLOGY
Dr. Andrew Woolfenden
1. Pharmacology of the DA system: imaging in vivo and in
vitro
2. Positron Emission Tomography (PET)
3. Animal models of neurodegenerative disease
4. Cell transplantation for the treatment of Parkinson's
Disease
1. Cognitive disorders with aging dementia and
Alzheimer’s disease
1. Myasthenia gravis
2. Vasculitic neuropathy
3. Adult muscular dystrophy
4. Immune polyneuropathies
1. Epilepsy and EEG
1. Stroke
2. Risk factors for cerebrovascular disease
3. Intracerebral hemorrhage
1. Neurology of HIV / AIDS
2. Neurophysiology as applied to #1
3. Neurology/Neurophysiology of spinal cord disease
4. Neurology of pregnancy
1. Neural stem cell (human)
2. Demyelinating neurological disease - MS
3. Brain transplantation
4. Neural tissue culture
1. Functional MRI
2. Movement disorders
3. Computational neuroscience
4. Clinical electrophysiology
1. Mechanisms for drug-induced complications in
Parkinson's disease
2. Cognitive and psychotic symptons in Parkinson's
disease
3. Studies on the progression of Parkinson's disease
1. Neurogenetics
2. Neuromuscular Diseases / EMG
3. Mitochondrial Disease
4. Myasthenia Gravis
1. Myasthenia gravis
2. Auto-antibodies
3. Pathogenesis of auto-immune disorders
1. Signal transduction
2. Proteomics
3. Neurological disease markers and drug targets
4. Cancer disease markers and drug targets
1. Headache disorders
1. Molecular genetics of neurological disease
Neuro-Oncology:
1. Systemic therapy for primary brain tumors
2. Molecular diagnosis in primary brain tumors
3. Neurologic effects of systemic cancer
1. Multiple Sclerosis
2. MRI Analysis
3. Novel MRI techniques for CNS disease
1. Multiple sclerosis
2. Epidemiology
3. Linked health data
4. drug effectiveness and adverse events
5. disease progression; prognosis
6. pregnancy
1. Movement disorders
2. Population studies
3. Clinical trials
1. Neuroscience
2. Synaptic transmission
3. Learning and memory
4. Pathogenesis of epilepsy
5. Stroke-related neuronal death
1. Cerebrovascular disorders - clinical aspects
Dr. Pippa Hawley
1. Symptom control, especially pain
Dr. Hugh Anton
1. Outcome measurement in rehabilitation
2. Rehabilitation of neurologic conditions and complex
trauma
3. Fatigue in neurological and neuromuscular disorders
1. Stroke rehabilitation
2. Cardiovascular training in stroke patients
1. Spinal cord injury rehabailitation
2. Rehabilitation outcomes
1. Spinal cord injury rehabilitation.
2. Autonomic dysfunctions following SCI
3. Cardiovascular control and SCI
4. Women's health and spinal cord injury
5. Sexual dysfunctions and SCI
1. Phenol motor point blocks for the treatment of Adductor
spasticity in MS
2. Botox for the treatment of thoracic outlet syndrome RCT botox vs saline
3. Injury patterns in international wheelchair rugby
tournament
1. Spinal cord injury
2. High lesion spinal cord injury/ventilator dependency
3. Patient education
1. Rehab medicine
2. Musculoskeletal abnormalities
3. Electrophysiology
1. Amputees & prosthetics
2. Acquired brain injury
3. Wound care
1. Prosthetics / Orthotics
2. Stroke rehabilitation
3. HIV / Inner City disability / rehabilitation
4. Renal rehabilitation
1. Cancer rehabilitation
2. Medical education
3. Brain injury / stroke rehabilitation
Dr. Doris Doudet
Dr. Howard Feldman
Dr. Gillian Gibson
Dr. Manouchehr Javidan
Dr. Dean Johnston
Dr. Robert Keyes
Dr. Seung Kim
Dr. Martin J. McKeown
Dr. Chong S. Lee
Dr. Michelle Mezei
Dr. Joel Oger
Dr. Steven Pelech
Dr. Gordan Robinson
Dr. Sian Spacey
Dr. Brian Thiessen
Dr. Tony Traboulsee
Dr. Helen Tremlett
Dr. Joseph Tsui
Dr. Yu Tian Wang
[email protected]
1
[email protected]
[email protected]
1
[email protected]
1
[email protected]
2
[email protected]
1
[email protected]
1
[email protected]
1-2
[email protected]
1
[email protected]
1
1-2
1
[email protected]
[email protected]
[email protected]
[email protected]
1
[email protected]
[email protected]
1
1
[email protected]
[email protected]
PALLIATIVE CARE & PAIN MANAGEMENT
1-2
[email protected]
PHYSICAL MEDICINE & REHABILITATION
Dr. Andrew Dawson
Dr. David Koo
Dr Andrei Krassioukov
Dr. Russell O'Connor
Dr. Andrea Townson
Dr. Andrew Travlos
Dr. Heather Underwood
Dr. Elliott Weiss
Dr. Jennifer K. Yao
[email protected]
2
[email protected]
1
[email protected]
[email protected]
1-2
1-2
[email protected]
[email protected]
[email protected]
1
[email protected]
[email protected]
6
RESPIROLOGY
Dr. Raja Abboud
Dr. Najib Ayas
Dr. Chris Carlson
Dr. Delbert Dorscheid
Dr. Kevin Elwood
Dr. Tharwat Fera
Dr. Mark Fitzgerald
Dr. John Fleetham
Dr. Nasreen Khalil
Dr. Stephen Lam
Dr. Robert Levy
Dr. Peter Pare
Dr. John Swiston
Dr. Jeremy Road
Dr. Frank Ryan
Ken Wilson
Dr. Mark Turner
Dr. Helen Ward
Dr. Pearce Wilcox
Dr. Jennifer Wilson
Dr. Moira Yeung
1. New drugs in COPD
2. Genetic risk factors predisposing some smokers to
emphysema
1. Meta-analysis in respiratory disease
2. The effects of sleep apnea on biologic markers
(metabolic, inflammatory and cardiovascular)
3. The public health consequences of sleep disordered
breathing
4. Adverse health and safety consequences of sleep
deprivation
1. Air pollution respiratory and cardiovascular effects
2. Occupational lung disease, particularly asthma
1. Asthma
2. Inflammation and apoptosis
3. Ischemia/Reperfusion cardiac injuries
1. Tuberculosis
2. Atypical mycobacterial disease
1. Asthma
2. COPD
1. Asthma
2. Tuberculosis
3. Pharmaeconomics
4. Outcome Evaluation
1. Respiratory sleep and neuromuscular disorders
1. Pathogenesis of idiopathic pulmonary fibrosis
2. Airway remodeling in asthma
1. Early detection of lung cancer
2. Optical Imaging
3. Chemoprevention
1. Lung transplantation
2. Pulmonary hypertension
1. Asthma and COPD
2. Genetics of lung & heart disease
1. Pulmonary Hypertension
2. Systematic reviews and Meta-analysis in respiratory
diseases
1. Respiratory neuromuscular disease
2. COPD
1. Obstructive sleep apnea
2. Pleural Disease
3. Upper airway imaging
1. Melanoma
2. Lymphoma, myeloma
3. GI tract cancers
4. Outcomes research.
1. Community acquired pneumonia pathways
2. Pleural effusions
3. Bronchoscopy in the elderly
1. Occupational Health
2. Environmental Health
3. Epidemiology
1. Cystic Fibrosis
2. Pulmonary complications of connective tissue disease
3. Pulmonary function testing and cardiopulmonary
exercise testing
+
2. Lung transplantation
1. Asthma
2. Occupational lung disease
3. Environmental lung diseases
1
[email protected]
[email protected]
1
[email protected]
2-3
[email protected]
1
[email protected]
2
[email protected]
1
1
[email protected]
[email protected]
[email protected]
1
[email protected]
1
[email protected]
1-2
[email protected]
2
[email protected]
1
[email protected]
[email protected]
1-2
[email protected]
1
[email protected]
1
[email protected]
1
[email protected]
1-2
[email protected]
several
[email protected]
[email protected]
1
[email protected]
1-2
[email protected]
[email protected]
1
[email protected]
1
[email protected]
[email protected]
RHEUMATOLOGY
Dr. Ken Blocka
Dr. Jolanda Cibere
Dr. Stephanie Ensworth
Dr. John Esdaile
Dr. John Kelsall
Dr. A.V. Klinkhoff
Dr. Diane Lacaille
Dr. G. Reid
Dr. Ian Tsang
1. Clinical research interest in full spectrum of rheumatic
diseases
1. Osteoarthritis
1. Systemic Lupus Erythematosus
2. Rheumatic diseases in pregnancy and anti-rheumatic
medications in pregnancy
3. Anti-phospholipid syndrome in pregnancy
4. Autoimmune causes of recurrent pregnancy loss or
infertility
1. Lupus
2. Rheumatoid Arthritis
3. Back disease
4. Osteoarthritis
1. Any Rheumatological Topic
1. KA treatment
2. Gold therapy in RA
3. Combination of gold & methotrexate for severe RA
4. Pharmaco kinetics of parentrel methotrexate
1. Rheumatoid Arthritis
2. SLE
3. Employment and Arthritis
4. Monitoring quality of care in Arthritis
1. General Rheumatology
1. Traditional Chinese Medicine in Rheumatic Diseases
[email protected]
7